| Literature DB >> 25796120 |
Volha Dzmitruk1, Aleksandra Szulc2, Dzmitry Shcharbin3, Anna Janaszewska2, Natallia Shcharbina4, Joanna Lazniewska2, Darya Novopashina5, Marina Buyanova5, Maksim Ionov6, Barbara Klajnert-Maculewicz7, Rafael Gómez-Ramirez8, Serge Mignani9, Jean-Pierre Majoral10, Maria Angeles Muñoz-Fernández11, Maria Bryszewska2.
Abstract
This paper examines a perspective to use newly engineered nanomaterials as effective and safe carriers for gene therapy of cancer. Three different groups of cationic dendrimers (PAMAM, phosphorus, and carbosilane) were complexed with anticancer siRNA and the biophysical properties of the dendriplexes created were analyzed. The potential of the dendrimers as nanocarriers for anticancer Bcl-xl, Bcl-2, Mcl-1 siRNAs and additionally a scrambled sequence siRNA has been explored. Dendrimer/siRNA complexes were characterised by various methods including fluorescence, zeta potential, dynamic light scattering, circular dichroism, gel electrophoresis and transmission electron microscopy. In this part of study, the transfection of complexes in HeLa and HL-60 cells was analyzed using both single apoptotic siRNAs and a mixture (cocktail) of them. Cocktails were more effective than single siRNAs, allowing one to decrease siRNAs concentration in treating cells. The dendrimers were compared as siRNA carriers, the most effective being the phosphorus-based ones. However, they were also the most cytotoxic on their own, so that in this regard the application of all dendrimers in anticancer therapy will be discussed.Entities:
Keywords: Anticancer siRNA; Cancer cells; Dendrimer; Nano-drug-delivery
Mesh:
Substances:
Year: 2015 PMID: 25796120 DOI: 10.1016/j.ijpharm.2015.03.034
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875